Log In
Print this Print this


Also known as: CA9-GM-CSF

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionActive immunotherapy using proprietary Antigen Delivery Cassette technology with the antigen carbonic anhydrase IX (CA9)
Molecular Target Carbonic anhydrase IX (CAIX)
Mechanism of ActionImmunotherapy
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPreclinical
Standard IndicationRenal cancer
Indication DetailsTreat renal cell carcinoma (RCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today